Alnylam Pharmaceuticals
ALNY
#657
Rank
$38.50 B
Marketcap
$288.41
Share price
3.60%
Change (1 day)
-11.20%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company